Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease.

Graves' disease (GD) is a common autoimmune disease (AID) that shares many of its susceptibility loci with other AIDs. The thyroid stimulating hormone receptor (TSHR) represents the primary autoantigen in GD, in which autoantibodies bind to the receptor and mimic its ligand, thyroid stimulating...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Brand, O, Barrett, J, Simmonds, M, Newby, P, McCabe, C, Bruce, C, Kysela, B, Carr-Smith, J, Brix, T, Hunt, P, Wiersinga, WM, Hegedüs, L, Connell, J, Wass, J, Franklyn, J, Weetman, A, Heward, J, Gough, S
Format:	Journal article
Język:	English
Wydane:	2009

Podobne zapisy

Association of the TSHR gene with Graves' disease: the first disease specific locus.
od: Dechairo, B, i wsp.
Wydane: (2005)

Association of the TSHR gene with Graves' disease: The first disease specific locus
od: Dechairo, B, i wsp.
Wydane: (2005)

Preliminary evidence for interaction of PTPN12 polymorphism with TSHR genotype and association with Graves' ophthalmopathy.
od: Syed, A, i wsp.
Wydane: (2007)

Genetics of thyroid autoimmunity and the role of the TSHR.
od: Brand, O, i wsp.
Wydane: (2010)

Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease.
od: Zeitlin, A, i wsp.
Wydane: (2008)

Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts.
od: Płoski, R, i wsp.
Wydane: (2010)

A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease.
od: Taylor, J, i wsp.
Wydane: (2006)

Tag SNP screening of the PDCD1 gene for association with Graves' disease.
od: Newby, P, i wsp.
Wydane: (2007)

Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease.
od: Zeitlin, A, i wsp.
Wydane: (2006)

Association of PTPN22 haplotypes with Graves' disease.
od: Heward, J, i wsp.
Wydane: (2007)

Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3.
od: Simmonds, M, i wsp.
Wydane: (2010)

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.
od: Hamilton, A, i wsp.
Wydane: (2014)

The CD40 Kozak SNP: a new susceptibility loci for Graves' disease?
od: Simmonds, M, i wsp.
Wydane: (2005)

Association of FcGRIIa with Graves' disease: a potential role for dysregulated autoantibody clearance in disease onset/progression.
od: Yesmin, K, i wsp.
Wydane: (2010)

Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
od: Simmonds, M, i wsp.
Wydane: (2006)

IL-13 and chromosome 5q31-q33: problems of identifying association within regions of linkage to Graves' disease.
od: Simmonds, M, i wsp.
Wydane: (2005)

Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease.
od: Simmonds, M, i wsp.
Wydane: (2010)

A systematic approach to the assessment of known TNF-alpha polymorphisms in Graves' disease.
od: Simmonds, M, i wsp.
Wydane: (2004)

Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.
od: Simmonds, M, i wsp.
Wydane: (2006)

A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect.
od: Simmonds, M, i wsp.
Wydane: (2007)

No association of an interleukin 4 gene promoter polymorphism with Graves' disease in the United Kingdom.
od: Heward, J, i wsp.
Wydane: (2001)

A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians.
od: Heward, J, i wsp.
Wydane: (2004)

Lack of association of the vitamin D receptor gene with Graves' disease in UK Caucasians.
od: Collins, J, i wsp.
Wydane: (2004)

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs.
od: Brand, O, i wsp.
Wydane: (2007)

Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-analysis.
od: Simmonds, M, i wsp.
Wydane: (2014)

Follow-up of potential novel Graves' disease susceptibility loci, identified in the UK WTCCC genome-wide nonsynonymous SNP study.
od: Newby, P, i wsp.
Wydane: (2010)

Polymorphisms of interleukin 4 receptor gene and interleukin 10 gene are not associated with Graves' disease in the UK.
od: Tait, K, i wsp.
Wydane: (2004)

Regression mapping of association between the human leukocyte antigen region and Graves disease.
od: Simmonds, M, i wsp.
Wydane: (2005)

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
od: Allahabadia, A, i wsp.
Wydane: (2001)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
od: Harper, L, i wsp.
Wydane: (2004)

Deteksi mutasi gen TSHR pada penderita penyakit graves di Puskesmas Sukoharjo Kabupaten Sukoharjo
od: , SLAMET, R. Agus Wibowo, i wsp.
Wydane: (2010)

Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease.
od: Collins, J, i wsp.
Wydane: (2003)

Cytokine gene polymorphisms in autoimmune thyroid disease.
od: Hunt, P, i wsp.
Wydane: (2000)

A nonsense mutation in exon 2 of the DNase I gene is not present in UK subjects with systemic lupus erythematosus and Graves' disease: Comment on the article by Rood et al.
od: Simmonds, M, i wsp.
Wydane: (2002)

Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom.
od: Collins, J, i wsp.
Wydane: (2004)

Sharing of susceptibility loci between autoimmune diseases: lack of association of the insulin gene region with Graves' disease.
od: Allahabadia, A, i wsp.
Wydane: (1999)

Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.
od: Boelaert, K, i wsp.
Wydane: (2010)

Age and gender predict the outcome of treatment for Graves' hyperthyroidism.
od: Allahabadia, A, i wsp.
Wydane: (2000)

Vascular Cell Adhesion Molecule-l (VCAM-l) in Graves' Disease: Its Association to Thyroid Status and Thyroid Receptor Stimulating Antibodies
od: Wan Nazaimoon, W.M., i wsp.
Wydane: (2004)

A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association.
od: Nithiyananthan, R, i wsp.
Wydane: (2000)